Representative Billy Tauzin, "a principal author of the new Medicare [3] drug law, will become president of the Pharmaceutical Research and Manufacturers of America [4], the chief lobby for brand-name drug companies." The Medicare law is generous to industry, forbidding price controls, regulations, or even negotiations with drug manufacturers "to secure lower prices for Medicare beneficiaries." Tauzin isn't alone; Thomas A. Scully, "the administration's main negotiator with Congress on the drug bill," is now a registered lobbyist for Abbott and Aventis. Powell Moore, "the Pentagon's chief lobbyist," is joining the law and lobbying firm McKenna Long & Aldridge [5], which has an "extensive national security practice." Senator Zell Miller [6] is also joining the firm, reports [7] The Hill.